Fundraising FoxNeon Therapeutics
Cambridge, US · Founded 2013 · Delaware corporation · 5 known investors
Find your way into Neon Therapeutics
Sign up to see every warm intro you have to Neon Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neon Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RG
Richard Gaynor, M.D.President, Research and Development2016–2020Richard Gaynor is an Executive Officer at Neon Therapeutics, a company developing personalized cancer vaccines based on immuno-oncology approaches. Gaynor holds an M.D. degree.
RA
Robert Ang, M.D.Executive
YA
EL
Eric LanderNamed on SEC filing
HD
Hugh DowdNamed on SEC filing
Board
CP
Cary Pfeffer, M.D.Board director
RK
SS
Stephen SherwinBoard directorInvestor at Third Rock Ventures
RT
Investors · 5
Nextech Investlisted by Nextech InvestZurich · $648K – $3.2M
How we know: Nextech Invest's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Sofinnova Ventureslisted by Sofinnova VenturesMenlo Park · $100K – $15M
How we know: Sofinnova Ventures's portfolio page · Not right? Tell us
Clal Biotechnology IndustriesreportedTel Aviv
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$106M disclosed across 1 of 2 rounds · 2016–2017
- Undisclosed amountSeries BDec 2017Source ↗
▶$106MraisedDec 2017 · 25 investors · BiotechnologyRule 506(b)
▶$106MraisedDec 2017 · 25 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard Gaynor, M.D.Executive Officer
- Cary Pfeffer, M.D.Director
- Robert KamenDirector
- Eric LanderDirector
- Robert Ang, M.D.Executive Officer
- Yasir Al-WakeelExecutive Officer
- Stephen SherwinDirector
- Hugh DowdExecutive Officer, Director
- Robert TepperDirector
- Offering amount
- $106M
- Amount sold
- $106M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Neon Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- Who are Neon Therapeutics's investors?
- Neon Therapeutics's investors include Nextech Invest, Sofinnova Ventures, Clal Biotechnology Industries, Third Rock Ventures, Wellington Management.
- How much funding has Neon Therapeutics raised?
- Neon Therapeutics has disclosed $106M raised across 1 of its 2 known rounds.
- Where is Neon Therapeutics headquartered?
- Neon Therapeutics is headquartered in Cambridge, US.